European
Drug Delivery Summit 2026

Welcome to the European Drug Delivery Summit 2026, where global pharmaceutical and drug delivery technology providers come together with leading experts and researchers to explore the latest developments in drug delivery technologies and formulation science.

The drug delivery field continues to face challenges in optimising pharmacokinetics, pharmacodynamics, and formulation strategies. This summit will address these challenges by showcasing new inhalation devices, transdermal systems, and combination modalities that improve targeted delivery and therapeutic effectiveness.

Join us to explore innovative approaches, connect with industry leaders, and help shape the future of drug delivery.

Next-gen formulation methods to enhance solubility in poorly soluble drugs

Explore innovative solubilisation and AI-enabled formulation strategies that enhance the bioavailability of poorly soluble and beyond Rule-of-Five drugs.

Advancements in long-acting and controlled-release systems

Evaluate long-acting and controlled-release systems, enhancing safety, efficacy, and patient convenience by optimising drug release rates and duration.

Targeted delivery to difficult-to-reach tissues across biological barriers

Gain insights into targeted delivery to CNS, ocular, and mucosal tissues, focusing on overcoming biological barriers and improving therapeutic outcomes.

Nanocarriers and advanced delivery platforms for precise targeted therapies

Examine nanocarrier platforms that enhance targeted and intracellular delivery, focusing on characterisation, safety, and development pathways to clinical use.

Drug-device combination products and intelligent connected delivery devices

Learn how combination products and connected delivery devices have been developed for self-administration, emphasising usability, safety, and EU MDR compliance.

Delivery technologies for new drug modalities and emerging biotherapeutics

Assess delivery methods for advanced biomolecules and novel drug modalities, including nucleic acids, PROTACs, next-generation peptides, and ADCs.

Expert Speakers

Past Attendees

hidden text

hidden text